Skip to content

To compare the incidence of post operative delirium with dexmedetomidine and fentanyl in postoperative cardiac patients 12th hourly for 7 days in ICU.

Incidence of Delirium with Dexmedetomidine compared with fentanyl based therapy in post operative cardiac surgical patients:A Randomized controlled single blinded study. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071553
Enrollment
150
Registered
2024-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I00-I99- Diseases of the circulatory system Health Condition 2: I20-I25- Ischemic heart diseases

Interventions

Intervention1: Dexmedetomidine,Fentanyl: incidence of Delirium with Dexmedetomidine compared with fentanyl based therapy in post operative cardiac surgical patients. Intervention2: Dexmedetomidine: De

Sponsors

Institue of medical science and sum hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of age group 18-80 years scheduled for on pump cardiac surgeries.

Exclusion criteria

Exclusion criteria: 1.Patients not giving consent 2.Patients with severe congestive heart failure,(ejection fraction less than 40),second degree heart blocks,neurological disorders,renal and liver failures. 3.If patient is hypotensive preoperatively. 4.If patient baseline heart rate is less than 55per min. 5.If patient has pacemaker insitu. 6.Patient getting reoperated. 7.Patient hypersensitive to opioids and known drug allergies.

Design outcomes

Primary

MeasureTime frame
To compare the incidence of postopertive delirium(confusion assessment method)with dexmedetomidine and fentanylTimepoint: 12th hourly for 7 days.

Secondary

MeasureTime frame
Duration of sedation and analgesia,trail of extubation done after 12 hours of shifting the patient to ICU, ,incidence of tachyarrythmias,haemodynamic parameters(HR,MAP,SPO2) and side effects like nausea and vomitingsTimepoint: 2,,6,12,24,48 hourly-sedation and analgesia

Countries

India

Contacts

Public ContactPavani paidi

Institue of medical science and sum hospital.

drranjitaacharya@gmail.com8763421899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026